Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

llion versus euro 45 million. In Q1 2010, net financial expenses benefited from a capital gain of euro 47 million on the sales of the stake in Novexel. Net financial expenses related to debt was down versus Q1 2010.

The effective tax rate was 28.5% versus 28.4% in Q1 2010.

Business net income(1) was euro 2,170 million, down 10.6%, or down 16.1% at constant exchange rates.

Business earnings per share(1) (EPS) was euro 1.66, down 10.8% versus the 2010 first-quarter figure. At constant exchange rates, business earnings per share(1) decreased by 16.1%. Excluding A/H1N1 sales, business earning per share(1) was stable on a reported basis and decreased by 6.0% at constant exchange rates.(1) See Appendix 9 for definitions of financial indicators, and Appendix 7 for reconciliation of business net income to consolidated net income attributable to equity holders of sanofi-aventis.

From business net income to consolidated net income attributable to equity holders of sanofi-aventis (see Appendix 7) In Q1 2011, the main reconciling items between business net income and consolidated net income attributable to equity holders of sanofi-aventis were:

  • A euro 736 million amortization charge against intangible assets arising on the application of purchase accounting to acquired companies (primarily Aventis: euro 536 million and Merial euro 80 million) and to acquired intangible assets (licenses/products: euro 50 million). This item has no cash impact on the Group.
  • A non-recurring amortization charge of euro 517 million due to the change of plan for Merial assets that were previously classified as held for sale or exchange in accordance with IFRS5: this charge corresponds to the depreciation and amortization of Merial assets that would have been recognized for the period from September 18, 2009 to December 31, 2010, had these assets not been classifi
    '/>"/>

    • SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

    Related medicine technology :

    1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
    8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
    9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
    10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
    11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... 2013  Hologic, Inc. (Hologic or the Company) ... manufacturer and supplier of premium diagnostics, medical imaging ... serving the healthcare needs of women, today announced ... U.S. clinical practice comparing breast cancer screening with ... 2D mammography alone showed a significant reduction in ...
    (Date:5/23/2013)... , May 23, 2013  Ameritox, the nation,s ... by Progressive Medical, Inc. to become part of ... clients manage pharmacy costs and improve the clinical ... a leading pharmacy benefit manager in the workers, ... medication compliance and pain management strategy for several ...
    (Date:5/23/2013)... , May 23, 2013 Israel Brain ... 2013 , Israel,s 1 st ... 14 th -15 th in Tel Aviv ... innovative city in the world by the Wall Street ... BrainTech Israel 2013 will showcase the latest breakthroughs in ...
    Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
    (Date:5/24/2013)... Paris, France: Routinely measuring fractional flow reserve (FFR) ... diagnosis of chest pain leads to significant changes ... according to results from a study reported at ... wire assessment influence management strategy at coronary angiography ... to assess whether routine assessment of FFR in ...
    (Date:5/24/2013)... at Oregon Health & Science University highlights an ingenious ... with the highly evasive HIV virus that causes AIDS. ... unique approach to develop its own HIV vaccine candidate, ... studies. This latest research finding will be published in ... Science . , "A major challenge in developing ...
    (Date:5/24/2013)... May 24, 2013 CBT News.com recently announced ... joins the web-based retail automotive industry news organization with 12 ... “I’m excited to join a group that’s so forward-thinking in ... of how online video content is on the rise.” , ... motorcycle business and segued into advertising at Cycle News and ...
    (Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Antigua (AICASA) has signed an articulation agreement with ... their students to study abroad in Antigua. ... three college credits after participating in a cell biology ... an articulation agreement with American University of Antigua ...
    (Date:5/24/2013)... half of recommended well-child visits had up to twice ... most of their visits, according to a study published ... . The study included more than 20,000 children enrolled ... conditions like asthma and heart disease were even more ... to the study. In fact, children with chronic ...
    Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
    ... singled out tumor specific alterations in cellular pathway ... is administered to patients suffering from multiple myeloma.researchers have ... that might improve chances of patients responding ... to frame tailor treatment to patients with multiple myeloma, ...
    ... an Indian American scientist, has held out a hope ... several diseases including cancer, HIV/AIDS and malaria. // ... would work against several diseases like cancer malaria and ... and Drug Administration (FDA) and are studying how to ...
    ... outbreaks of the deadly Ebola virus in Africa have been ... //Hotly debated has been whether these wild ape deaths were ... published in the journal Science puts this debate to rest, ... at a single site. The study also provides new hope ...
    ... NSW has grown two-fold, according to a recent study. // ... on the increase and presently 50% of the adult and 25% ... ,In 1997 the incidence of diabetics in NSW was 4.3% ... 6.9 and 8.4% until last year. 90% o which belonged to ...
    ... to a study finding of Ron Matsusaki, a doctor from ... of 14,000 //residents on the western tip of Canada's Prince ... in patients who live near a toxic waste site. ... pesticides 80 percent of which is used for potato farming ...
    ... the latest findings of the researchers at Mayo Clinic, Minnesota ... developing// enlarged prostates up to 50%.’ The results of this ... ,Benign prostatic hyperplasia, a condition that could make urination ... the doctors. More than half of the men in their ...
    Cached Medicine News:Health News:Tailor-made Cancer Treatment for Multiple Myeloma Patients Offered by Mayo Clinic 2Health News:Indian American Scientist at Work on Multi-targeted Drug 2Health News:Ebola-Outbreak Kills 5000 Gorillas 2Health News:Ebola-Outbreak Kills 5000 Gorillas 3
    ... is designed to play a key ... research involves proteomics, cytomics or genomics. ... enhanced firmware, powerful Optima eXPert software ... L-XP delivers superior functionality, optimized user ...
    ... integrated chemistry system brings versatility in ... smaller laboratory. A model of innovation ... chemistry system features state-of-the-art Dimension testing ... environment, in a flexible. affordable, easy-to-use ...
    The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
    ... convenience make the RD/Hitachi 902 the ... workload laboratory. Compact, sample selective clinical ... 26 tests on board (including 3 ... tests per hour respectively up to ...
    Medicine Products: